{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:13:44Z","timestamp":1788300824611,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128905","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:59:09Z","timestamp":1783439949000},"page":"128905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunity gaps for several vaccine preventable diseases in Norway"],"prefix":"10.1016","volume":"89","author":[{"given":"Audun","family":"Aase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove Karin","family":"Herstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margrethe","family":"Greve-Isdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gro","family":"Tunheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10441","key":"10.1016\/j.vaccine.2026.128905_bb0005","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","article-title":"Contribution of vaccination to improved survival and health: modelling 50 years of the expanded programme on immunization","volume":"403","author":"Shattock","year":"2024","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.vaccine.2026.128905_bb0010","author":"Norwegian Institute of Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128905_bb0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41579-024-01064-8","article-title":"Pertussis vaccines, epidemiology and evolution","volume":"22","author":"Domenech de Cell\u00e8s","year":"2024","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128905_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3947\/ic.2024.0117","article-title":"Pertussis in the post-COVID-19 era: resurgence, diagnosis, and management","volume":"57","author":"Kang","year":"2025","journal-title":"Infect Chemother"},{"key":"10.1016\/j.vaccine.2026.128905_bb0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coviro.2020.05.009","article-title":"Waning immunity and re-emergence of measles and mumps in the vaccine era","volume":"40","author":"Yang","year":"2020","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2026.128905_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2025.101591","article-title":"Measles outbreaks in the United States in 2025: practice, policy, and the canary in the coalmine","volume":"65","author":"Hewitt","year":"2025","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.vaccine.2026.128905_bb0035","author":"ECDC"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128905_bb0040","first-page":"153","article-title":"Measles outbreak--California, December 2014\u2013February 2015","volume":"64","author":"Zipprich","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128905_bb0045","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/cid\/ciu105","article-title":"Outbreak of measles among persons with prior evidence of immunity, New York City, 2011","volume":"58","author":"Rosen","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128905_bb0050","author":"ECDC"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128905_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15081618","article-title":"Mumps in the vaccination age: global epidemiology and the situation in Germany","volume":"15","author":"Beleni","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128905_bb0060","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-051873","article-title":"Mumps in vaccinated children and adolescents: 2007-2019","volume":"148","author":"Shepersky","year":"2021","journal-title":"Pediatrics"},{"issue":"38","key":"10.1016\/j.vaccine.2026.128905_bb0065","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.38.1700642","article-title":"Large outbreak of mumps virus genotype G among vaccinated students in Norway, 2015 to 2016","volume":"23","author":"Veneti","year":"2018","journal-title":"Euro Surveill"},{"issue":"433","key":"10.1016\/j.vaccine.2026.128905_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5945","article-title":"Vaccine waning and mumps re-emergence in the United States","volume":"10","author":"Lewnard","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2026.128905_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127791","article-title":"Persistence of measles, mumps, and rubella immunity following childhood vaccination in Australian health science students: a cohort study","volume":"65","author":"Schoenfisch","year":"2025","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128905_bb0080","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128905_bb0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10096-010-1104-y","article-title":"What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories","volume":"30","author":"Guiso","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128905_bb0090","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/infdis\/jiz381","article-title":"Is there a correlate of protection for measles vaccine?","volume":"221","author":"Plotkin","year":"2019","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128905_bb0095","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1038\/s41467-021-23114-y","article-title":"Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries","volume":"12","author":"Berbers","year":"2021","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.vaccine.2026.128905_bb0100","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1016\/j.vaccine.2024.05.015","article-title":"Seroprotection against tetanus in the Italian general population","volume":"42","author":"Bagordo","year":"2024","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2026.128905_bb0105","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2025.30.50.2500450","article-title":"Maternal and infant immunity against Bordetella pertussis, Norway, 2020 to 2023","volume":"30","author":"Greve-Isdahl","year":"2025","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2026.128905_bb0110","author":"Helsenorge"},{"issue":"16","key":"10.1016\/j.vaccine.2026.128905_bb0115","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.16.20147-en","article-title":"The Norwegian immunisation register--SYSVAK","volume":"17","author":"Trogstad","year":"2012","journal-title":"Euro Surveill"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2026.128905_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"van Gageldonk","year":"2008","journal-title":"J Immunol Methods"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128905_bb0125","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1128\/CVI.05081-11","article-title":"Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid","volume":"18","author":"van Gageldonk","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128905_bb0130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CVI.05537-11","article-title":"Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus","volume":"19","author":"Smits","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128905_bb0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/biol.1994.1062","article-title":"Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines","volume":"22","author":"Kayhty","year":"1994","journal-title":"Biologicals"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128905_bb0140","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1017\/S0950268813001532","article-title":"High risk of a large measles outbreak despite 30 years of measles vaccination in the Netherlands","volume":"142","author":"Mollema","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2026.128905_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128309","article-title":"Increasing incidence of pertussis before scheduled primary school booster vaccinations in Norway, 1998-2019","volume":"76","author":"Kristoffersen","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128905_bb0150","author":"ECDC"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128905_bb0155","article-title":"Diphtheria and tetanus immunity status among Greek adults: results from a nationwide seroprevalence study","volume":"12","author":"Papagiannis","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"31","key":"10.1016\/j.vaccine.2026.128905_bb0160","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1016\/j.vaccine.2017.05.080","article-title":"A cross-reacting material CRM197 conjugate vaccine induces diphtheria toxin neutralizing antibody response in children and adolescents infected or not with HIV","volume":"35","author":"Silva","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128905_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108912","article-title":"Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents","volume":"234","author":"Riggenbach","year":"2022","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128905_bb0170","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/cid\/ciae470","article-title":"The effects of vaccination status and age on clinical characteristics and severity of measles cases in the United States in the postelimination era, 2001\u20132022","volume":"80","author":"Leung","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128905_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02089","article-title":"Mumps outbreaks in vaccinated populations-is it time to re-assess the clinical efficacy of vaccines?","volume":"11","author":"Connell","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128905_bb0180","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1473-3099(20)30442-4","article-title":"Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis","volume":"21","author":"Schenk","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128905_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8010066","article-title":"Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy","volume":"8","author":"Anichini","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128905_bb0190","article-title":"Seroprevalence of measles-, mumps-, and rubella-specific antibodies in the German adult population - cross-sectional analysis of the German health interview and examination survey for adults (DEGS1)","volume":"7","author":"Friedrich","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128905_bb0195","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.vaccine.2017.12.075","article-title":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","volume":"36","author":"Seagle","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128905_bb0200","article-title":"Unveiling immunity gaps and determining a suitable age for a third dose of the measles-containing vaccine: a strategic approach to accelerating measles elimination","volume":"32","author":"Mehra","year":"2025","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128905_bb0205","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/infdis\/jiz380","article-title":"What is the evidence to support a correlate of protection for measles? A systematic review","volume":"221","author":"Bolotin","year":"2020","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:22:42Z","timestamp":1788297762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"alternative-id":["S0264410X26007140"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128905","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunity gaps for several vaccine preventable diseases in Norway","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128905"}}